Notification of major holdings - Pentwater

Summary by AI BETAClose X

Pentwater Capital Management LP has notified Ondine Biomedical Inc. of a change in its major holdings, specifically an acquisition of financial instruments. As of September 1, 2026, Pentwater Capital Management LP now holds a total of 3.001803% of Ondine Biomedical Inc.'s shares outstanding through financial instruments, a decrease from its previous holding of 4.053088%. The total number of shares outstanding in the issuer is 16,846,666.00.

Disclaimer*

UK 100

Latest directors dealings